<DOC>
	<DOC>NCT01222962</DOC>
	<brief_summary>The study was designed to assess the effect of food on the extent and rate of absorption of Dihydroartemisinin (DHA) and Piperaquine Phosphate (PQP) administered as a fixed dose combination (Eurartesim™).</brief_summary>
	<brief_title>Food Interaction Study on the Pharmacokinetics of Eurartesim™ (DHA and PQP)in Healthy Male Adult Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Malaria, Falciparum</mesh_term>
	<criteria>Caucasian healthy males aged between 18 and 50 years(inclusive). Body Mass Index (BMI) between 19.0 kg/m2 and 27.0 kg/m2 inclusive, with a minimum body weight of 75 kg. Agreed to use two approved methods of contraception from Screening and until 90 days after administration of the study drug Had given written informed consent to participate in this study in accordance with local regulations. Had received or was anticipated to receive a prescription medication within 14 days prior to the start of dosing or an overthecounter medicine 48 hours prior to the start of dosing. Abnormal laboratory test results deemed clinically significant by the Medical Officer. Positive urine drug test (e.g. opiates and cannabinoids) or alcohol breath test. History of significant drug allergies or significant allergic reaction. Receipt of blood or blood products, or loss or donation of 450 mL or more of blood within 90 days before the first dose administration.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2010</verification_date>
</DOC>